Riskpilot← Back to searchSign inGet full accessPULMOVET A/S
A/SActiveCVR 29691916Stumpedyssevej 26Research and experimental development on natural sciences and engineering · NACE 7210Est. 2006— employees
Revenue 2024
DKK 0
EBITDA margin
—
Equity ratio
35.9%
Financial strength
Net profit 2024
DKK 0
+100% vs 2023
| Revenue | DKK 0 | — |
| EBITDA | DKK 0 | — |
| Net profit | DKK 0 | +100% |
| Total assets | DKK 36K | +0% |
| Equity | DKK 13K | +0% |
| Employees | — | — |
Legal name
PULMOVET A/S
CVR number
29691916
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
17. juli 2006
Share capital
DKK 500.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren eller af den samlede bestyrelse
Company purpose
Selskabets formål er at udvikle og markedsføre teknologier og nye produkter til behandling af åndedrætsbesvær hos dyr, især behandling af heste.
Address
Stumpedyssevej 26
Phone
+4548205900
Email
hfn@equinehaler.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -10 | -11 | -10 | -9 | -5 | -6 | -4 | 9 | -3 | -6 | 0 | 0 | 0 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -10 | -11 | -10 | -281 | -5 | -6 | -4 | -331 | -15 | -6 | -5 | -4 | 0 |
| Depreciation & amort. | -0 | -0 | -0 | -2.193 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -10 | -11 | -10 | -2.474 | -5 | -6 | -4 | -331 | -15 | -6 | -5 | -4 | 0 |
| Net financials | 10 | 7 | -17 | 950 | 7 | 7 | 12 | 13 | 14 | -0 | -0 | 0 | 0 |
| Profit before tax | -1 | -4 | -27 | -1.525 | 2 | 0 | 8 | -318 | -1 | -6 | -5 | -4 | 0 |
| Tax | -0 | -1 | 0 | 123 | -500 | 87 | 2 | 230 | 11 | -0 | -0 | -0 | -0 |
| Net profit | -0 | -3 | -27 | -1.647 | 501 | -86 | 6 | -548 | -12 | -6 | -5 | -4 | 0 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2.963 | 2.975 | 2.978 | 177 | 673 | 587 | 594 | 46 | 35 | 44 | 37 | 36 | 36 |
| Equity | 1.836 | 1.833 | 1.814 | 167 | 668 | 582 | 588 | 40 | 28 | 22 | 17 | 13 | 13 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.127 | 1.143 | 1.164 | 10 | 5 | 5 | 5 | 6 | 6 | 22 | 20 | 23 | 23 |
| Total debt | 1.127 | 1.143 | 1.164 | 10 | 5 | 5 | 5 | 6 | 6 | 22 | 20 | 23 | 23 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20122024
Equity ratio
35.9%
This company
38.2%
Market median
+6% vs market
20122024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20122024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20122024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20122024
Debt / equity
1.79×
This company
0.62×
Market median
-189% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CJ Management | Management | 2006 | — | — |
HF Management | Management | 2006 | — | — |
CP Management | Management | 2006 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2017 | — | — | |
| Chairman | 2011 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2011 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
EQUINE HEALTHCARE ApS | Company | 90.0% | 90.0% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
EQUINE HEALTHCARE ApS
PULMOVET A/S Board members of PULMOVET A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Calvin John London | Management | 0 companies |
| Helle Funch Nielsen | Management | 0 companies |
| Clive Page | Management | 0 companies |
| Birte Funch Nielsen | Chairman | 0 companies |
| Per Michael Riis | Chairman | 0 companies |
| Stig Lytke Brejl | Board of Directors | 0 companies |
| David John Marlin | Board of Directors | 0 companies |